Synutra Announces Preliminary Second Quarter Fiscal 2015 Financial Results

QINGDAO, China and ROCKVILLE, Md., Oct. 10, 2014 /PRNewswire/ -- Synutra International, Inc. SYUT, ("Synutra" or the "Company"), which owns subsidiaries in China that produce, distribute and sell nutritional products for infants, children and adults, today announced unaudited preliminary second quarter 2015 results and raised full year 2015 guidance.

For the second quarter ended September 30, 2014, the Company anticipates revenue in the range of $106-110 million, representing year-over-year revenue growth of at least 20%. Net income attributable to common stockholders is expected to be in the range of $9-10 million, compared to $6.1 million in the second quarter of fiscal 2014, representing year-over-year growth of at least 50%. These positive results were due to increased IMF sales at the distributor and retail channels.

Based on its strong preliminary second quarter and first half fiscal 2015 results, the Company now maintains its forecasted revenue range of $450-500 million, while raising its fiscal 2015 net income guidance from a range of $50-60 million to $55-65 million.

Mr. Liang Zhang, Chairman and CEO of Synutra said, "We are pleased to see continued strong demand for our core formula brands. In the second fiscal quarter, we experienced sequential and year-over-year increases in both revenue and net profit, despite significant market competition.  Our success this quarter was primarily due to increased shipment volumes in a traditionally slow season as a result of our increased strategic marketing efforts.  We expect this momentum to continue in the coming quarters, resulting in strong top line growth and greater operating leverage in fiscal 2015."

Synutra plans to release its second quarter financial results in early November.

About Synutra International, Inc.

Synutra International, Inc. SYUT is a leading infant formula company in China. It principally produces, markets and sells its products through its operating subsidiaries under the "Shengyuan" or "Synutra" name, together with other complementary brands. It focuses on selling premium infant formula products, which are supplemented by more affordable infant formulas targeting the mass market as well as other nutritional products and ingredients. It sells its products through an extensive nationwide sales and distribution network covering all provinces and provincial-level municipalities in mainland China. As of June 30, 2014, this network comprised over 680 independent distributors and over 550 independent sub-distributors who sell Synutra products in approximately 23,000 retail outlets.

Forward-looking Statements

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that are based on our current expectations, assumptions, estimates and projections about Synutra International, Inc. and its industry. All statements other than statements of historical fact in this release are forward-looking statements. In some cases, these forward-looking statements can be identified by words or phrases such as "anticipate," "believe," "continue," "estimate," "expect," "intend," "is/are likely to," "may," "plan," "should," "will," "aim," "potential," "continue," or other similar expressions. The forward-looking statements included in this press release relate to, among others, Synutra's goals and strategies; its future business development, financial condition and results of operations, particularly the progress on the new drying facility project in France; the expected growth of the nutritional products and infant formula markets in China; market acceptance of Synutra's products; the safety and quality of Synutra's products; Synutra's expectations regarding demand for its products; Synutra's ability to stay abreast of market trends and technological advances; competition in the infant formula industry in China; PRC governmental policies and regulations relating to the nutritional products and infant formula industries and our ability to meet governmental requirements, and general economic and business conditions in China. These forward-looking statements involve various risks and uncertainties. Although Synutra believes that the expectations expressed in these forward-looking statements are reasonable, these expectations may turn out to be incorrect. Synutra's actual results could be materially different from the expectations. Important risks and factors that could cause actual results to be materially different from expectations are generally set forth in Synutra's filings with the Securities and Exchange Commission. The forward-looking statements are made as of the date of this press release. Synutra International, Inc. undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which the statements are made or to reflect the occurrence of unanticipated events.

SOURCE Synutra International, Inc.